Someone buys a bottle of L-citrulline because they have been told it will increase nitric oxide.
They may want better circulation.
They may have cold hands and feet, high blood pressure, erectile dysfunction, reduced exercise endurance, or known cardiovascular disease.
They take the powder every morning and expect their arteries to open.
Perhaps they feel a better pump during exercise.
Perhaps their blood pressure improves slightly.
Or perhaps nothing happens.
Then they wonder:
“Does citrulline actually work, or did I waste my money?”
The honest answer is that citrulline can work.
But not in the simplistic way supplement marketing often explains it.
Citrulline does not travel directly into your arteries and release nitric oxide. Your body must absorb it, convert it into arginine, deliver that arginine to the endothelial lining, move it into the correct cells, and then use a functioning enzyme system to produce nitric oxide.
That is a long biological pathway.
If the pathway is functioning reasonably well, citrulline may provide useful support.
If the pathway is impaired, adding more citrulline may be like delivering extra bricks to a construction site where the workers, tools, and electricity are failing.
The bricks arrived.
The building still did not get built.
What I want you to understand is this:
Citrulline supplies raw material. Your biology determines whether that material becomes useful nitric oxide.
Citrulline is an amino acid.
After you consume it, much of it bypasses the liver and travels to the kidneys. The kidneys convert a meaningful portion of that citrulline into arginine.
Arginine then enters the circulation, where it can be used by the endothelial lining of your blood vessels.
The pathway looks like this:
Citrulline → kidneys → arginine → endothelial cells → nitric oxide
Research in humans shows that oral L-citrulline can raise circulating arginine more effectively than simply taking an equivalent amount of oral arginine in some settings. Arginine is heavily processed by the intestine and liver, while citrulline bypasses much of that initial breakdown.
Research links:
https://pubmed.ncbi.nlm.nih.gov/17662090/
https://pubmed.ncbi.nlm.nih.gov/23022123/
https://pubmed.ncbi.nlm.nih.gov/17513441/
This is why citrulline is often described as a more reliable way to increase blood arginine.
But raising arginine is only the first step.
Your endothelial cells still need to turn that arginine into nitric oxide.
They do this using an enzyme called endothelial nitric oxide synthase, or eNOS.
You can think of eNOS as the machine that turns the raw material into the final product.
When that machine is working correctly, it uses arginine, oxygen, and supporting cofactors to produce nitric oxide.
Nitric oxide then helps blood vessels relax. It also contributes to vascular signalling, blood-flow regulation, platelet control, and protection of the endothelial surface. Reduced nitric-oxide availability is a central feature of endothelial dysfunction in hypertension, diabetes, atherosclerosis, and heart failure.
https://pubmed.ncbi.nlm.nih.gov/17323842/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9015729/
This is where the supplement story becomes more complicated.
No.
Turning 40 does not suddenly stop the kidneys from converting citrulline into arginine.
That is too absolute.
However, vascular function often changes with age.
The endothelial lining may become less responsive. Oxidative stress can increase. Inflammation can rise. Blood vessels may become stiffer. The body may produce less available nitric oxide, destroy it more rapidly, or become less responsive to its signal.
The conversion from citrulline to arginine may still occur.
The larger problem may be what happens after arginine reaches the blood.
Age-related endothelial dysfunction involves several overlapping changes, including oxidative stress, inflammatory signalling, endothelial-cell aging, reduced eNOS activity, and faster destruction of nitric oxide.
https://pubmed.ncbi.nlm.nih.gov/19619671/
https://pubmed.ncbi.nlm.nih.gov/22972557/
https://pubmed.ncbi.nlm.nih.gov/37921669/
This means a 25-year-old athlete and a 65-year-old person with hypertension, diabetes, kidney disease, or atherosclerosis may take the same dose and experience very different results.
The younger person may already have a healthy nitric-oxide pathway. Citrulline provides a little more raw material, and the pathway uses it.
The older person may absorb and convert the citrulline normally, but the endothelial machinery may be impaired.
Food is the input.
Biology is the interpreter.
This does not mean citrulline is useless after 40.
In fact, some human studies suggest that older adults and people with impaired vascular function may experience improvements in blood pressure, arterial stiffness, or flow-mediated dilation.
But the response is inconsistent because the biology underneath the supplement is inconsistent.
A recent meta-analysis involving middle-aged and older adults found average reductions of approximately 4 mmHg systolic and 2.5 mmHg diastolic pressure from citrulline or watermelon-derived citrulline interventions. Those are averages, not guarantees. Some people responded more, while others did not respond meaningfully.
https://pubmed.ncbi.nlm.nih.gov/40789388/
The question is not simply:
“Are you over 40?”
The better questions are:
Is your endothelial lining still responsive?
Is your blood pressure elevated?
Is nitric oxide being destroyed by oxidative stress?
Is ADMA blocking the pathway?
Is eNOS properly coupled?
Are you physically active?
Is glucose regulation healthy?
Are the kidneys functioning normally?
Are medications lowering your blood pressure already?
The pattern matters more than the birthday.
ADMA stands for asymmetric dimethylarginine.
It is produced naturally when certain proteins are broken down.
ADMA resembles arginine closely enough that it can compete with arginine at nitric oxide synthase.
In simple language:
Arginine is trying to enter the machine.
ADMA is standing in the doorway.
When ADMA is elevated, nitric oxide synthase may have more difficulty using arginine efficiently. Higher ADMA concentrations have been associated with endothelial dysfunction, atherosclerosis, hypertension, diabetes, heart failure, and kidney impairment.
https://pubmed.ncbi.nlm.nih.gov/10978245/
https://pubmed.ncbi.nlm.nih.gov/15465797/
https://pubmed.ncbi.nlm.nih.gov/23470077/
This is why looking only at arginine may be misleading.
You can have plenty of arginine in the blood and still have reduced nitric-oxide production if ADMA is high or eNOS is dysfunctional.
Some researchers therefore examine the arginine-to-ADMA ratio rather than either marker alone.
A higher ratio generally suggests that more arginine is available relative to the inhibitor blocking the pathway. Lower arginine-bioavailability ratios have been associated with endothelial dysfunction and cardiovascular risk.
https://pubmed.ncbi.nlm.nih.gov/21632053/
Citrulline may improve this ratio by raising arginine.
A small study in middle-aged men found that citrulline increased circulating arginine, improved the arginine-to-ADMA ratio, raised nitric-oxide metabolites, and modestly improved arterial-stiffness measures.
https://pubmed.ncbi.nlm.nih.gov/21067832/
That is encouraging.
But it still does not mean that citrulline removes the reason ADMA became elevated.
ADMA may rise with:
Kidney dysfunction
Insulin resistance
High blood pressure
Oxidative stress
Inflammation
Atherosclerosis
Poor cardiovascular health
Reduced activity
Certain metabolic conditions
If the root environment remains unchanged, citrulline may improve the ratio temporarily without fully repairing the endothelial system.
It may help the pathway.
It does not automatically repair the reason the pathway became impaired.
There is another problem called eNOS uncoupling.
When eNOS is properly coupled, it produces nitric oxide.
When it becomes uncoupled, the enzyme can begin producing more superoxide instead.
Superoxide is a reactive oxygen species.
It can react with nitric oxide and form peroxynitrite, which further damages the endothelial environment and reduces the amount of nitric oxide available to the artery.
In plain English:
A healthy machine produces nitric oxide.
A damaged machine may produce more oxidative stress instead.
This can become a loop:
Oxidative stress damages eNOS.
Damaged eNOS produces more oxidative stress.
Nitric oxide falls.
The artery becomes less responsive.
Supplying additional arginine or citrulline does not always correct that entire process. eNOS function also depends on cofactors, redox balance, endothelial health, oxygen availability, and cellular signalling.
https://pubmed.ncbi.nlm.nih.gov/21172428/
This is where most supplement explanations stop too early.
They tell you:
“Citrulline raises arginine.”
Correct.
“Arginine produces nitric oxide.”
Sometimes.
But they often leave out the condition of the enzyme performing the conversion.
If the endothelial system is under heavy oxidative stress, the problem may not be a shortage of substrate.
The problem may be impaired machinery.
This is especially relevant in someone with:
Existing coronary artery disease
Long-standing hypertension
Diabetes or repeated glucose spikes
Chronic kidney disease
Smoking exposure
Significant inflammation
Advanced endothelial dysfunction
Poor sleep or untreated sleep apnea
Severe physical inactivity
Elevated ADMA
Existing heart failure
A person with heart disease may still benefit from citrulline.
But the presence of heart disease makes the rest of the pathway more important, not less.
The evidence is promising in selected areas, but it is not strong enough to call citrulline a proven heart-protection therapy.
Small human trials have reported improvements in:
Blood-vessel dilation
Arterial stiffness
Central blood pressure
Exercise blood flow
Selected heart-failure measurements
Functional capacity in certain populations
A short trial involving patients with coronary artery disease reported improved endothelial function after citrulline supplementation.
https://pubmed.ncbi.nlm.nih.gov/27648629/
A small randomized study in stable systolic heart failure reported improvements in ejection fraction, endothelial function, and functional class. The study was small and should be viewed as preliminary rather than proof of improved long-term outcomes. (PubMed)
https://pubmed.ncbi.nlm.nih.gov/23224924/
Trials in hypertensive postmenopausal women and other vascular-risk groups have reported improvements in endothelial function, exercise blood flow, muscle oxygenation, or central blood pressure.
https://pubmed.ncbi.nlm.nih.gov/36297080/
https://pubmed.ncbi.nlm.nih.gov/38931289/
https://pubmed.ncbi.nlm.nih.gov/41374029/
However, not every trial is positive.
A study in older men using 6 grams daily for six days found no significant improvement in resting blood pressure, wave reflection, or arterial stiffness.
https://pubmed.ncbi.nlm.nih.gov/37755854/
Meta-analyses generally suggest small average blood-pressure reductions, with meaningful variation based on dose, duration, baseline blood pressure, health status, and study design.
https://pubmed.ncbi.nlm.nih.gov/30788274/
https://pubmed.ncbi.nlm.nih.gov/30206378/
https://pubmed.ncbi.nlm.nih.gov/31889969/
What is missing?
We do not have strong evidence that citrulline:
Reverses coronary plaque
Prevents heart attacks
Prevents strokes
Replaces blood-pressure medication
Replaces exercise
Repairs advanced endothelial disease by itself
Improves survival in established cardiovascular disease
That does not make it worthless.
It defines its proper role.
Citrulline is a pathway-support tool, not a cardiovascular cure.
At this point, the main idea should be clear. The question is not only whether citrulline raises arginine. The question is whether the rest of the nitric-oxide system can use that arginine effectively.
In the paid section, I’m going to walk through the testing, dosing, timing, medication cautions, who may benefit, who should avoid it, and how I would test the response without guessing.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.